HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of lavage or intravenous antibiotics at cesarean section.

Abstract
The route of administration of prophylactic antibiotics was studied in a randomized prospective trial. Cefoxitin was administered to high-risk patients at cesarean section by three treatment regimens: intravenous antibiotic (2 g) for eight doses, irrigation of uterus and peritoneum with 2 g of antibiotic, and a combination of intravenous and irrigation as described. A control group received no antibiotic prophylaxis. The incidence of febrile morbidity was similar in each treatment group: intravenous, two of 39 (5%); irrigation, three of 42 (7%); intravenous and irrigation, two of 38 (5%), and were all significantly lower than the control group 14 of 39 (36%) (P less than .05). Similar results were found when prevention of endometritis was the end point: intravenous, two of 39 (5%); irrigation, two of 42 (5%); intravenous and irrigation, two of 38 (5%) compared with 13 of 39 (33%) in the control group (P less than .05). Administration of antibiotics by irrigation is equally effective in preventing postoperative febrile morbidity and endomyometritis as intravenous dosing and a combination of intravenous and irrigation. This affords a potential cost savings.
AuthorsJ P Elliott, J F Flaherty
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 67 Issue 1 Pg. 29-32 (Jan 1986) ISSN: 0029-7844 [Print] United States
PMID3510014 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cefoxitin
Topics
  • Adult
  • Cefoxitin (administration & dosage)
  • Cesarean Section (adverse effects)
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Endometritis (prevention & control)
  • Female
  • Humans
  • Infusions, Parenteral
  • Pregnancy
  • Premedication (methods)
  • Prospective Studies
  • Random Allocation
  • Risk
  • Surgical Wound Infection (prevention & control)
  • Therapeutic Irrigation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: